Ascentage Pharma Group International (NASDAQ:AAPG - Get Free Report) shares gapped down before the market opened on Tuesday . The stock had previously closed at $20.49, but opened at $20.06. Ascentage Pharma Group International shares last traded at $19.91, with a volume of 5,660 shares.
Analysts Set New Price Targets
Separately, JPMorgan Chase & Co. initiated coverage on Ascentage Pharma Group International in a research note on Thursday, March 27th. They issued an "overweight" rating for the company.
Get Our Latest Research Report on AAPG
Ascentage Pharma Group International Stock Performance
The firm's fifty day simple moving average is $19.54.
Ascentage Pharma Group International Company Profile
(
Get Free Report)
Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
Further Reading
Before you consider Ascentage Pharma Group International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ascentage Pharma Group International wasn't on the list.
While Ascentage Pharma Group International currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
